Francisca FERRER MARÍN

Santaliestra M, Ferrer-Marin F, Alvarez-Larran A; MPN Spanish Group (GEMFIN). Review of the risk of thrombosis or bleeding upon abrupt anagrelide discontinuation in patients with essential thrombocythemia. Ann Hematol. 2022 Nov;101(11):2563-2564. doi: 10.1007/s00277-022-04956-y. Epub 2022 Aug 17. No abstract available. PubMed PMID: 35978180.

AÑO: 2022; IF: 3.5

35978180

Hernandez-Boluda JC, Pastor-Galan I, Arellano-Rodrigo E, Raya JM, Perez-Encinas M, Ayala R, Ferrer-Marin F, Velez P, Mora E, Fox ML, Hernandez-Rivas JM, Xicoy B, Mata-Vazquez MI, Garcia-Fortes M, Perez-Lopez R, Angona A, Cuevas B, Senin A, Ramirez MJ, Ramirez-Payer A, Gomez-Casares MT, Martinez-Valverde C, Magro E, Steegmann JL, Duran MA, Garcia-Hernandez C, Gasior M, de Villambrosia SG, Alvarez-Larran A, Pereira A; Spanish MPN Group (GEMFIN). Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis. Br J Haematol. 2022 Nov;199(4):529-538. doi: 10.1111/bjh.18440. Epub 2022 Sep 12. PubMed PMID: 36089912.

AÑO: 2022; IF: 6.5

36089912

Alvarez-Larran A, Angona A, Andrade-Campos M, Soledad Noya M, Teresa Gomez-Casares M, Cuevas B, Caballero G, Garcia-Hernandez C, Garcia-Gutierrez V, Palomino A, Ferrer-Marin F, Isabel Mata-Vazquez M, Moreto A, Magro E, Murillo I, Manuel Alonso-Dominguez J, Maria Guerra J, Guerrero L, Maria Raya J, Perez-Encinas M, Carreno-Tarragona G, Fox L, Pastor-Galan I, Bellosillo B, Hernandez-Boluda JC; MPN Spanish Group (GEMFIN). Cytoreductive treatment in patients with CALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia. Br J Haematol. 2021 Mar;192(6):988-996. doi: 10.1111/bjh.16988. Epub 2020 Aug 3. PubMed PMID: 32745264.

AÑO: 2021; IF: 8.615

32745264

Barbui T, De Stefano V, Carobbio A, Iurlo A, Alvarez-Larran A, Cuevas B, Ferrer Marin F, Vannucchi AM, Palandri F, Harrison C, Sibai H, Griesshammer M, Bonifacio M, Elli EM, Trotti C, Koschmieder S, Carli G, Benevolo G, Ianotto JC, Goel S, Falanga A, Betti S, Cattaneo D, Arellano-Rodrigo E, Mannelli L, Vianelli N, Doyle A, Gupta V, Wille K, Tremblay D, Mascarenhas J. Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients. Leukemia. 2021 Oct;35(10):2989-2993. doi: 10.1038/s41375-021-01279-1. Epub 2021 May 19. No abstract available. PubMed PMID: 34012132; PubMed Central PMCID: PMC8132485.

AÑO: 2021; IF: 12.883

34012132

Perez Encinas MM, Sobas M, Gomez-Casares MT, Abuin Blanco A, Noya Pereira MS, Raya JM, Andrade-Campos MM, Alvarez Larran A, Lewandowski K, Lukasz S, Hernandez Boluda JC, Ferrer-Marin F, Fox ML, Golos A, Gasior Kabat M, Magro Mazo E, Czyz A, Martin Martin A, Bellosillo Paricio B, Quinteiro Garcia C, Gonzalez Martin JM, Stuckey R. The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study. Eur J Haematol. 2021 Mar;106(3):371-379. doi: 10.1111/ejh.13561. Epub 2020 Dec 30. PubMed PMID: 33275803.

AÑO: 2021; IF: 3.674

33275803